LATEST NEWS
Thermo Fisher Scientific Introduces NGS-Based Solution for Expanded Carrier Screening Research
Thermo Fisher Scientific has introduced a new next-generation sequencing (NGS)-based solution that enables reproductive health researchers to more efficiently analyze a broad range of...
Read More
Bicameral, Bipartisan Group of Lawmakers Form Congressional Personalized Medicine Caucus
The Personalized Medicine Coalition (PMC) today announces its support for a new bicameral, bipartisan Congressional Personalized Medicine Caucus formed by Sens. Tim Scott (R-SC)...
Read More
Governor Cooper Announces over 460 Jobs in Durham as Eli Lilly and Company Selects North Carolina for Major Pharmaceutical Plant
Eli Lilly and Company (NYSE: LLY), a global healthcare and biopharmaceutical company, will invest over $470 million and create more than 460 new jobs...
Read More
Quest Diagnostics Acquires Blueprint Genetics to Broaden Access to Actionable Insights for Genetic and Rare Diseases
Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced that it has acquired Blueprint Genetics in an all-cash equity...
Read More
LabCorp to Adopt Thermo Fisher Scientific’s Ion Torrent Genexus Next-Generation Sequencing System and Pan-Cancer Assay for Use in Oncology Research and Development
LabCorp® (NYSE: LH) announced it will adopt the Ion Torrent Genexus System* and Oncomine Precision Assay* for use in research and development of companion...
Read More
Dr. Thomas J. Lynch Jr. named new president and director of Fred Hutch
Dr. Thomas J. Lynch Jr. will become Fred Hutchinson Cancer Research Center’s new president and director, the organization announced today. Lynch, a well-known cancer...
Read More
New post: Thermo Fisher Scientific Introduces NGS-Based Solution for Expanded Carrier Screening Research